895240-71-8

Basic information

• Product Name: 4-Methyl-3-(3-methoxypropoxyl)benzoic acid
• Synonyms: 3-(3-Methoxypropoxy)-4-methylbenzoic acid;4-Methyl-3-(3-methoxypropoxyl)benzoic acid
• CAS NO: 895240-71-8
• Molecular Formula: C₁₂H₁₆O₄
• Molecular Weight: 224.25
• EINECS: 1533716-785-6
• Mol File: 895240-71-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Density: 1.131
• CAS DataBase Reference: 4-Methyl-3-(3-methoxypropoxyl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methyl-3-(3-methoxypropoxyl)benzoic acid(895240-71-8)
• EPA Substance Registry System: 4-Methyl-3-(3-methoxypropoxyl)benzoic acid(895240-71-8)

Safety Data

• Hazardous Substances Data: 895240-71-8(Hazardous Substances Data)

Usage

General Description

4-Methyl-3-(3-methoxypropoxyl)benzoic acid is a chemical compound with the molecular formula C14H18O4 and a molecular weight of 250.29 g/mol. It is a derivative of benzoic acid and contains a 4-methyl group, a 3-methoxypropoxyl group, and a carboxylic acid group. 4-Methyl-3-(3-methoxypropoxyl)benzoic acid is commonly used in the synthesis of pharmaceuticals and as an intermediate in organic chemical reactions. It possesses properties that make it suitable for use as a building block in the production of various fine chemicals and pharmaceutical products. However, it is important to handle and use this compound with caution, as it may pose health and environmental risks if not properly managed.

Upstream product

• 3556-86-3 methyl 4-methyl-3-hydroxybenzoate 
• 586-30-1 3-hydroxy-4-methylbenzoic acid 
• 895240-72-9 3-(3-methoxy-propoxy)-4-methyl-benzoic acid methyl ester 

Relevant articles and documents

3, 4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION

The invention relates to the use of (3,4-di-, 3,3,4-tri, 3,4,4-tri- or 3,3,4,4-tetra-)substituted pyrrolidine compounds for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; compounds that are part of a subclass of these substituted pyrrolidine compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (= disorder) that depends on activity of renin; new compounds that are part of a subclass of these substituted pyrrolidine compounds; pharmaceutical formulations comprising said substituted pyrrolidine compounds, and/or a method of treatment comprising administering said substituted pyrrolidine compounds, a method for the manufacture especially of said new substituted pyrrolidine compounds, as well as novel intermediates, starting materials and/or partial steps for their synthesis. The substituted pyrrolidine compounds are of the formula (I), wherein R1, R2, R3, R4, R5 and T are defined as in the specification.